Literature DB >> 4005332

Combinations of evoked potential amplitude measurements in relation to psychiatric diagnosis.

C Shagass, R A Roemer, J J Straumanis, R C Josiassen.   

Abstract

The purposes of this investigation were (1) to determine the extent to which single nonredundant measures, derived from optimal combinations of evoked potential (EP) amplitude measurements, could differentiate between various groups of psychiatric patients and between patients and nonpatients, and (2) to assess the replicability of such discriminations. Somatosensory, visual, and auditory EPs were recorded from 15 locations in 253 unmedicated patients and 99 nonpatients. Multivariate statistical methods were used to reduce the amplitude measurements to sets of factor scores that met specified criteria for entry into discriminant analyses between pairs of the following groups: nonpatients, neuroses, personality disorders, schizophrenias, schizotypal/borderlines, major depressives, and manics. Sensitivity, specificity, and predictive value were assessed for discriminant scores. The discriminant scores yielded many differences between groups, most of which were replicable in split-half analyses. Among these were differences between all six patient groups and nonpatients, and between schizophrenics and nonpsychotics. Split-half discriminant analyses were also performed with 12 measures that were obtained by taking the means of factor scores grouped by sensory modality, time, and spatial location; these variables, used without preselection, provided several replicable diagnostic discriminations.

Entities:  

Mesh:

Year:  1985        PMID: 4005332     DOI: 10.1016/0006-3223(85)90150-7

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  3 in total

Review 1.  Topographic mapping of EEG and evoked potentials in psychiatry: delusions, illusions, and realities.

Authors:  M W Torello
Journal:  Brain Topogr       Date:  1989       Impact factor: 3.020

2.  Do cholesterol-lowering agents affect brain activity? A comparison of simvastatin, pravastatin, and placebo in healthy volunteers.

Authors:  R W Harrison; C H Ashton
Journal:  Br J Clin Pharmacol       Date:  1994-03       Impact factor: 4.335

3.  Somatosensory system deficits in schizophrenia revealed by MEG during a median-nerve oddball task.

Authors:  Ming-Xiong Huang; Roland R Lee; Kathleen M Gaa; Tao Song; Deborah L Harrington; Cathy Loh; Rebecca J Theilmann; J Christopher Edgar; Gregory A Miller; Jose M Canive; Eric Granholm
Journal:  Brain Topogr       Date:  2009-11-27       Impact factor: 3.020

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.